In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.
Why Princeton Professor rates BlinkLab’s autism & ADHD screening app
ASX:BB1
MCAP $16.26M
This browser does not support the video element.